Gut and Vaginal Microbiota Profile Study for HIV Women

Launched by PEKING UNION MEDICAL COLLEGE HOSPITAL · Aug 10, 2023

Keywords

ClinConnect Summary

This clinical trial is studying how the balance of bacteria in the vagina, known as vaginal microbiota, may affect the risk of women living with HIV acquiring human papillomavirus (HPV) infection. HPV is a common virus that can lead to changes in the cervix, which may cause issues like cervical lesions. The researchers believe that an imbalance in vaginal bacteria could make these women more susceptible to HPV and potentially lead to more serious cervical problems.

The trial is currently looking for women who are living with HIV, including those who are pregnant. To participate, women must be willing to sign a consent form and cannot be virgins. Participants can expect to share information about their health and undergo tests related to their vaginal microbiota and HPV. This study aims to better understand the connection between vaginal bacteria and HPV in women with HIV, which could help improve health outcomes for those affected.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • HIV women （including pregnant）;
• • sign consent paper
• Exclusion Criteria:
• • virgin or maiden